A proof-of-concept study of SB-751689 [ronacaleret] in men and post-menopausal women with a fractured distal radius.

Trial Profile

A proof-of-concept study of SB-751689 [ronacaleret] in men and post-menopausal women with a fractured distal radius.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Ronacaleret (Primary)
  • Indications Fracture
  • Focus Proof of concept; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 14 Apr 2010 Additional trial location [China] identified as reported by ClinicalTrials.gov.
    • 11 Sep 2009 Results presented at the 31st Annual Meeting of the American Society for Bone and Mineral Research.
    • 18 Dec 2008 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top